[ad_1]
Puma shares tumbled 13% on Wednesday after the German sportswear maker narrowed its profit forecast for the year, citing cautious consumer sentiment and higher freight costs.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...